
Cellectis
ALCLS | PA
Overview
Corporate Details
- ISIN(s):
- FR0010425595 (+2 more)
- LEI:
- 5493000KKX5VQ37Q2W83
- Country:
- France
- Address:
- 8 RUE DE LA CROIX JARRY, 75013 PARIS
- Website:
- https://cellectis.com/en
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Cellectis is a clinical-stage biopharmaceutical company pioneering the development of allogeneic CAR T-cell immunotherapies for cancer treatment. The company leverages its proprietary TALEN® gene-editing technology to engineer T-cells from healthy donors, creating "off-the-shelf" therapeutic product candidates. This universal approach is designed to provide readily available treatments for a broad patient population, overcoming the logistical challenges of personalized, patient-specific therapies. Cellectis's technology aims to enhance product safety and efficacy by addressing key challenges such as Graft-versus-Host Disease and host rejection. The company's innovation is supported by a robust intellectual property portfolio and strategic partnerships with global pharmaceutical firms.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Cellectis.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-05 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle relative au nombre total des droits de vote et d’actions …
|
French | 83.2 KB | |
2025-06-05 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Monthly information on share capital and company voting rights
|
English | 84.7 KB | |
2025-05-21 22:30 |
Pre-Annual General Meeting Information
L’Assemblée Générale Mixte de Cellectis se tiendra le 26 juin 2025
|
French | 44.7 KB | |
2025-05-21 22:30 |
Pre-Annual General Meeting Information
Cellectis’ Annual Shareholders General Meeting to be Held on June 26, 2025
|
English | 84.0 KB | |
2025-05-12 22:30 |
Earnings Release
Cellectis publie ses résultats financiers du premier trimestre 2025
|
French | 232.9 KB | |
2025-05-12 22:30 |
Earnings Release
Cellectis Reports Financial Results for the First Quarter 2025
|
English | 216.6 KB | |
2025-05-07 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle relative au nombre total des droits de vote et d’actions …
|
French | 83.3 KB | |
2025-05-07 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Monthly information on share capital and company voting rights
|
English | 84.8 KB | |
2025-05-06 22:30 |
Report Publication Announcement
Cellectis publiera ses résultats financiers du premier trimestre le 12 mai 2025
|
French | 67.7 KB | |
2025-05-06 22:30 |
Report Publication Announcement
Cellectis to Report First Quarter Financial Results on May 12, 2025
|
English | 77.3 KB | |
2025-04-28 22:39 |
Regulatory News Service
Cellectis présente une approche non virale d’édition du génome et des innovatio…
|
French | 190.3 KB | |
2025-04-28 22:30 |
Regulatory News Service
Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the AS…
|
English | 75.1 KB | |
2025-04-07 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle relative au nombre total des droits de vote et d’actions …
|
French | 122.2 KB | |
2025-04-07 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Monthly information on share capital and company voting rights
|
English | 91.5 KB | |
2025-03-13 23:46 |
Annual Report
Cellectis publie ses résultats financiers du quatrième trimestre 2024 et de l’e…
|
French | 250.5 KB |
Automate Your Workflow. Get a real-time feed of all Cellectis filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Cellectis via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |